Key facts
- This page summarizes Danielle Watson's Form 4 filing for HeartSciences Inc. (HSCS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 09 Jul 2026, 21:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Represents the Issuer's restricted stock units (the "RSUs") granted to the Reporting Person under the Issuer's 2023 Equity Incentive Plan, as amended, pursuant to the approval of the Issuer's board of directors (the "Board"). Each vested RSU shall be settled by delivery to the Reporting Person of one share of the Issuer's common stock, $0.001 par value per share, upon satisfaction of the Conditions (as defined below).
Footnote F2
The RSUs shall vest subject to the satisfaction of the following conditions (the "Conditions"): (i) occurrence of a closing of the merger (the "Closing") pursuant to a Merger Agreement dated June 22, 2026, among the Issuer, Cordis Acquisition, LLC, Fortitude Mining Holdings, Inc. and Fortitude Mining HoldCo, LLC; and (ii) (x) 1/4th of the RSUs shall vest on the three-month anniversary of the date of the Closing and (y) thereafter, 1/4th of the RSUs shall vest on each subsequent three-month anniversary of the initial vesting date, such that all of the RSUs shall fully vest on the one-year anniversary of the date of the Closing, (continued to footnote 3)
Footnote F3
in each case provided that the Reporting Person is continuously employed in any capacity by the Issuer or any of its subsidiaries from the date of the Closing through each applicable vesting date, subject to certain qualifying termination rights by the Issuer or the Reporting Person.
SEC remarks
Chief Financial Officer